BackNovozymes A/S Overview

Novozymes A/S Total Assets

Track Novozymes A/S's total assets ($17B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$16.83B
↑ 2.88% YoYΔ $471.30M vs prior year quarter

Peer trimmed avg / median

Loading

Novozymes A/S Total Assets History

Loading

Novozymes A/S vs. peers: Total Assets Comparison

Loading

Novozymes A/S Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Novozymes A/S (NVZMF) FAQ

As of the most recent data (September 2026), NVZMF shows a total assets of $17B. That compares with $16B in the prior-year period — up 2.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVZMF's total assets is now $17B (was $16B) — a 2.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novozymes A/S is outperforming or lagging.

Tracking NVZMF's total assets over time shows whether Novozymes A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $17B That compares with $16B in the prior-year period — up 2.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Novozymes A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $17B) with ownership activity and broader fundamentals.